An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma

Condition:   Non-Hodgkin Lymphoma, Follicular Lymphoma Interventions:   Drug: Mosunetuzumab SC;   Drug: Tiragolumab;   Drug: Atezolizumab;   Other: Tocilizumab Sponsor:   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials